Indobufen

Indobufen
Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	B01AC10 (WHO) ;
Identifiers
	IUPAC name 2-(4-(1-Oxoisoindolin-2-yl)phenyl)butanoic acid;
CAS Number	63610-08-2 ;
PubChem CID	107641;
ChemSpider	96823 ;
UNII	6T9949G4LZ;
KEGG	D07141 ;
ChEMBL	ChEMBL1765292 ;
Chemical and physical data
Formula	C18H17NO3
Molar mass	295.338 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(O)C(c1ccc(cc1)N3C(=O)c2ccccc2C3)CC;
	InChI InChI=1S/C18H17NO3/c1-2-15(18(21)22)12-7-9-14(10-8-12)19-11-13-5-3-4-6-16(13)17(19)20/h3-10,15H,2,11H2,1H3,(H,21,22) ; Key:AYDXAULLCROVIT-UHFFFAOYSA-N ;
	(what is this?) (verify)

Indobufen is a platelet aggregation inhibitor.^[1] It acts as a reversible cyclooxygenase inhibitor.^[2]

References

^ The Merck Index (12th ed.). p. 4991.
^ Eligini S, Violi F, Banfi C, Barbieri SS, Brambilla M, Saliola M, et al. (January 2006). "Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism". Cardiovascular Research. 69 (1): 218–26. doi:10.1016/j.cardiores.2005.07.013. PMID 16154551.

This drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by expanding it.